Marios Koumourtzis, MD, University of Athens Medical School, Andreas Syggros Hospital, Athens, Greece, talks on the need for more real-world data on the use of chlormethine gel for the treatment of mycosis fungoides, a subtype of cutaneous T-cell lymphoma (CTCL). Dr Koumourtzis reports that chlormethine gel has been shown to have an increasing response rate over time, with over 50% of patients achieving a complete repose after 9 months in a Greek study. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
